Today: 9 June 2026
Browse Category

NASDAQ:AMPG 20 May 2026 - 9 June 2026

AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
9 June 2026
·
AmpliTech Jumps on 5G Win, Eyes North America Sales

AmpliTech Jumps on 5G Win, Eyes North America Sales

AmpliTech received U.S. and Canadian certification for its full indoor 5G Native DAS hardware, enabling immediate commercial sales and integration across North America. Shares rose about 14% in premarket trading after the announcement. The company said it has orders from a North American mobile network operator, with shipments set to begin later this year.
20 May 2026
··

Stock Market Today

  • Invest in India’s Top 500 Companies with 3 Low-Cost Index Funds
    June 9, 2026, 10:10 AM EDT. Investors can access India's top 500 companies efficiently through three non-overlapping index funds: Nifty 100 (large-cap), Nifty Midcap 150, and Nifty Smallcap 250. The Nifty 100 Index Fund includes India's top 100 large-cap companies by market capitalization, spanning 17 sectors, and offers resilience in downturns. Common holdings such as HDFC Bank, Reliance Industries, and Infosys provide exposure to key economic sectors. Using these three funds prevents portfolio overlap, ensuring true diversification across market segments. Choices for Nifty 100 Index Funds include Axis, HDFC, and Bandhan, with options for systematic investment plans (SIPs). This strategy offers low cost, broad exposure, and balanced risk for investors seeking diversified growth in Indian equities.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Go toTop